Risk Factors for the Progression of Mild Cognitive Impairment in Different Types of Neurodegenerative Disorders

doi:10.1155/2018/6929732

Chia Nan University of Pharmacy & Science Institutional Repository > 中心級單位 > 通識教育中心 > 期刊論文 > Item 310902800/32220

請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/32220

標題:	Risk Factors for the Progression of Mild Cognitive Impairment in Different Types of Neurodegenerative Disorders
作者:	Chen, Pei-Hao Cheng, Shih-Jung Lin, Hui-Chi Lee, Chuo-Yu Chou, Chih-Ho
貢獻者:	MacKay Mem Hosp, Dept Neurol Mackay Med Coll, Dept Med Natl Taipei Univ Technol, Grad Inst Mech & Elect Engn Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol Tamkang Univ, Grad Inst Chem Chi Mei Med Ctr, Dept Neurol Chia Nan Univ Pharm & Sci
關鍵字:	Alzheimers Association Workgroups Society Task-Force Diagnostic Guidelines National Institute Clinical Dementia Older-Adults Disease Recommendations Management Decline
日期:	2018
上傳時間:	2019-11-15 15:45:40 (UTC+8)
出版者:	HINDAWI LTD
摘要:	Objective. Mild cognitive impairment (MCI) is a transitional state between normal aging and early dementia. It has a heterogeneous etiology and clinical course. This study aimed to examine the factors associated with the progression of MCI in different types of dementia disorders. Method. A retrospective, longitudinal, observational study of outpatients with MCI was conducted at a medical center in northern Taiwan. Patient medical records were reviewed, and risk factors were analyzed by multivariate analysis. Results. Among 279 patients with MCI, 163 (58.4%), 68 (24.4%), and 48 (17.2%) were diagnosed with Alzheimer's disease, vascular cognitive impairment, and Lewy body diseases, respectively. During the observation period, 37.2% of patients progressed to dementia. Older age and a higher Clinical Dementia Rating Scale-Sum of Boxes were associated with the risk of progression. Hyperlipidemia was associated with a decreased risk. Converters were more likely to receive an antidementia prescription. Conclusion. Our study suggests the importance of comprehensive clinical profiling, risk factor assessment, and detailed drug history evaluations in improving our understanding and management of dementia subtypes.
link:	http://dx.doi.org/10.1155/2018/6929732
關聯:	Cell Biochemistry and Biophysics, v.2018, ID 6929732
顯示於類別:	[通識教育中心] 期刊論文

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
10.1155-2018-6929732.pdf		1561Kb	Adobe PDF	327	檢視/開啟
index.html		0Kb	HTML	1318	檢視/開啟

在CNU IR中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....